.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Multi-Omics for Mothers and Infants (MOMI) Consortium represents a transformative global initiative aimed at decoding the biological mechanisms behind adverse pregnancy outcomes. These complications, which include preterm birth, preeclampsia, and stillbirth, remain a significant challenge for maternal health systems worldwide. Specifically, the burden of these outcomes is disproportionately high in low- and middle-income countries (LMICs). By combining diverse data sources, the consortium seeks to identify critical biological signatures that could lead to better diagnostic tools. This massive undertaking involves a cohort of over 24,000 pregnant women from various international sites.
To understand the multifactorial drivers of these conditions, researchers employ an integrative multi-omics approach. This strategy encompasses genomics, metabolomics, proteomics, and nutrient testing. Consequently, scientists can map the complex interactions between genetics and the environment. Furthermore, the consortium focuses on site-specific signatures, acknowledging that local factors often influence health outcomes. Therefore, the data collected from sites in Bangladesh, Pakistan, Tanzania, and Zambia provides a rich tapestry of information. These efforts allow clinicians to move beyond traditional risk factors toward molecular-based precision medicine.
A vital component of this global network is the Interdisciplinary Group for Advanced Research on Birth Outcomes (GARBH-Ini), a DBT India Initiative. This partnership highlights India's leading role in addressing maternal health challenges through high-quality cohort studies. Additionally, five analytical partners and three bioinformatics teams support the consortium’s rigorous data harmonisation. As a result, the project ensures that findings are robust and applicable across different populations. Notably, the study protocol emphasizes the importance of paired socioeconomic and clinical data to provide a holistic view of pregnancy health.
The primary goal of the MOMI study is to translate molecular findings into enhanced clinical care. By identifying early biomarkers, healthcare providers may soon implement novel therapeutic interventions. Moreover, the initiative paves the way for developing affordable diagnostic tools tailored for resource-limited settings. Ultimately, the consortium aims to reduce maternal and neonatal morbidity by addressing the root causes of pregnancy complications. This research fosters a deeper understanding of placental health and its impact on the long-term well-being of both mothers and infants.
The consortium aims to define the biological mechanisms associated with preterm birth, small for gestational age, preeclampsia, and stillbirth. It focuses on identifying omics-based signatures to improve diagnostic and therapeutic tools in LMICs.
The GARBH-Ini, supported by the DBT India Initiative, provides a specialized cohort and clinical data. This collaboration ensures that the diverse biological and socioeconomic landscape of India is represented in global maternal health research.
Researchers are using an integrative approach that includes genomics, proteomics, metabolomics, and nutrient testing. These layers of data help identify molecular drivers that contribute to different pregnancy outcomes.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The MOMI Consortium integrates multi-omics to identify biological signatures for adverse pregnancy outcomes like preterm birth and stillbirth in LMICs....
5 months ago
Integrating prompt medical nutrition therapy into ICU protocols prevents muscle wasting, decreases secondary infections, and accelerates recovery. Leading intensivists urge healthcare teams to treat targeted feeding as an indispensable therapy that curbs downstream hospitalization expenses.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday
A propensity-matched study shows ultrasound-guided pulsed radiofrequency of the lumbar sympathetic ganglion is non-inferior to fluoroscopy for painful diabetic neuropathy, reducing needle passes, procedure time, and radiation exposure while achieving equal pain relief.
Today
